SCHEMBL3857490

SCHEMBL3857490

CC[C@@]1(n2cnc3c(S)ncnc32)O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNPH1 O43598 8/20 0.43
P2RY1 P47900 2/20 0.43
TAS1R3 Q7RTX0 2/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
PRKAB2 O43741 1/20 0.43
TRPM2 O94759 1/20 0.43
LDHA P00338 1/20 0.43
ADRB2 P07550 1/20 0.43
FBP1 P09467 1/20 0.43
SRC P12931 1/20 0.43
ADORA1 P30542 1/20 0.43
P2RY2 P41231 1/20 0.43
PRKAG1 P54619 1/20 0.43
PRKAA2 P54646 1/20 0.43
PDE4D Q08499 1/20 0.43
KCNH2 Q12809 1/20 0.43
PRKAA1 Q13131 1/20 0.43
PDE3A Q14432 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
P2RY11 Q96G91 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5801879 0.89 DNPH1 (0.44) DNPH1P2RY1TAS1R3TAS1R1PRKAB2
SCHEMBL3859625 0.86 DNPH1 (0.45) DNPH1P2RY1TAS1R3TAS1R1PRKAB2
SCHEMBL30211839 0.81 P2RY1 (0.54) DNPH1P2RY1TAS1R3TAS1R1PRKAB2
SCHEMBL8440659 0.81 P2RX3 (0.49) P2RY1SRCP2RY2SMN1; SMN2RNASEL
SCHEMBL15210133 0.81 P2RY1 (0.53) DNPH1P2RY1TAS1R3TAS1R1PRKAB2
SCHEMBL1085901 0.81 P2RX1 (0.59) P2RY1TRPM2SRCP2RY2SMN1; SMN2
SCHEMBL17515130 0.80 DNPH1 (0.45) DNPH1P2RY1TAS1R3TAS1R1PRKAB2
SCHEMBL6712740 0.80 P2RY1 (0.56) DNPH1P2RY1TAS1R3TAS1R1PRKAB2
SCHEMBL3858345 0.79 P2RX3 (0.49) P2RY1SRCP2RY2SMN1; SMN2RNASEL
SCHEMBL4982512 0.79 P2RY1 (0.53) DNPH1P2RY1TAS1R3TAS1R1PRKAB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1825254-A4 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY PROMETHEUS LAB INC (US) 2009-01-14 EP disclosed
EP-1825254-A2 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY Prometheus Laboratories, Inc. (US) 2007-08-29 EP disclosed
US-20060216726-A1 Method for optimizing thiopurine efficacy and toxicity using mass spectrometry PROMETHEUS LABORATORIES INC. (US) 2006-09-28 US disclosed
WO-2006055527-A2 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY PROMETHEUS LABORATORIES INC. (US) 2006-05-26 WO disclosed